BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 5565740)

  • 1. Retarded depression and the dopamine metabolism.
    Korf J; van Praag HM
    Psychopharmacologia; 1971; 19(2):199-203. PubMed ID: 5565740
    [No Abstract]   [Full Text] [Related]  

  • 2. [The probenecid test. Evaluation in clinical medicine of cerebral metabolism of serotonin and dopamine].
    Véron JP; Mérienne L
    Nouv Presse Med; 1972 Feb; 1(8):537-9. PubMed ID: 4258943
    [No Abstract]   [Full Text] [Related]  

  • 3. Serotonin and dopamine disturbances in patients with unipolar depression and Parkinsonism.
    Mendlewicz J; Vanderheyden JE; Noel G
    Adv Exp Med Biol; 1981; 133():753-67. PubMed ID: 6172024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine metabolism in depressions, psychoses, and Parkinson's disease: the problem of the specificity of biological variables in behaviour disorders.
    Praag HM; Korf J; Lakke JPWF ; Schut T
    Psychol Med; 1975 May; 5(2):138-46. PubMed ID: 1161952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Central metabolism of dopamine and serotonin. III. Preliminary findings on the relations between dopamine metabolism and purine metabolism in the nervous system].
    Campanella G; Orefice G; Carrieri P; Mandarini A; Buscaino GA
    Acta Neurol (Napoli); 1976; 31(5):571-9. PubMed ID: 138341
    [No Abstract]   [Full Text] [Related]  

  • 6. Cerebral metabolites in cerebrospinal fluid as a biochemical approach to the brain.
    Moir AT; Ashcroft GW; Crawford TB; Eccleston D; Guldberg HC
    Brain; 1970; 93(2):357-68. PubMed ID: 4912291
    [No Abstract]   [Full Text] [Related]  

  • 7. Central monoamine metabolism in Parkinson's disease.
    Chase TN; Ng LK
    Arch Neurol; 1972 Dec; 27(6):486-91. PubMed ID: 5083866
    [No Abstract]   [Full Text] [Related]  

  • 8. Predictive value of the probenecid test for the effect of L-DOPA therapy in Parkinson's disease.
    Lakke JP; Korf J; Van Praag HM; Schut T
    Nat New Biol; 1972 Apr; 236(68):208-9. PubMed ID: 4553111
    [No Abstract]   [Full Text] [Related]  

  • 9. [Central metabolism of dopamine and serotonin. II. Significance of cerebrospinal fluid HVA and 5-HIAA changes in extrapyramidal and cerebellar syndromes].
    Buscaino GA; Mandarini A; Campanella G; Carrieri P; Orefice G
    Acta Neurol (Napoli); 1976; 31(5):565-70. PubMed ID: 138340
    [No Abstract]   [Full Text] [Related]  

  • 10. Biogenic amine disturbances in cerebrospinal fluid in parkinsonism and unipolar depression: use of the probenecid method.
    Vanderheyden JE; Noel G; Mendlewicz J
    Neuropsychobiology; 1981; 7(3):137-51. PubMed ID: 6164951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Central metabolism of dopamine and serotonin. I. Determination of cerebrospinal fluid levels of HVA and 5-HIAA by the probenecid test (modified)].
    Carrieri P; Campanella G; Mandarini A; Orefice G; Buscaino GA
    Acta Neurol (Napoli); 1976; 31(5):558-64. PubMed ID: 1015382
    [No Abstract]   [Full Text] [Related]  

  • 12. Parkinsonism-dementia and amyotrophic lateral sclerosis of Guam. Effect of probenecid on monoamine catabolite levels in cerebrospinal fluid.
    Chase RN; Schnur JA; Brody JA; Gordon EK
    Arch Neurol; 1971 Jul; 25(1):9-13. PubMed ID: 5146413
    [No Abstract]   [Full Text] [Related]  

  • 13. Predicting response to levodopa.
    Lakke JP; Korf J; van Praag HM
    Lancet; 1971 Jul; 2(7716):164-5. PubMed ID: 4104491
    [No Abstract]   [Full Text] [Related]  

  • 14. Acid monoamine metabolites in cerebrospinal fluid from patients with presenile dementia (Alzheimer's disease).
    Gottfires CG; Roos BE
    Acta Psychiatr Scand; 1973; 49(3):257-63. PubMed ID: 4715071
    [No Abstract]   [Full Text] [Related]  

  • 15. Amine metabolism in the human brain: further evaluation of the probenecid test.
    Korf J; Van Praag HM
    Brain Res; 1971 Dec; 35(1):221-30. PubMed ID: 5134227
    [No Abstract]   [Full Text] [Related]  

  • 16. Cerebrospinal fluid amine metabolites in affective illness: the probenecid technique.
    Goodwin FK; Post RM; Dunner DL; Gordon EK
    Am J Psychiatry; 1973 Jan; 130(1):73-9. PubMed ID: 4345466
    [No Abstract]   [Full Text] [Related]  

  • 17. The metabolism of brain dopamine in human parkinsonism.
    Hornykiewicz O
    Riv Patol Nerv Ment; 1970 Oct; 91(5):281-6. PubMed ID: 5525774
    [No Abstract]   [Full Text] [Related]  

  • 18. CSF homovanillic acid: an index of dopaminergic activity.
    Curzon G
    Adv Neurol; 1975; 9():349-57. PubMed ID: 125031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid 5-hydroxyindoleacetic acid (5HIAA) and homovanillic acid (HVA) following probenecid in unipolar depressives treated with amitriptyline.
    Bowers MB
    Psychopharmacologia; 1972; 23(1):26-33. PubMed ID: 5018977
    [No Abstract]   [Full Text] [Related]  

  • 20. Dopamine action and disorders of neurotransmitter balance.
    Birkmayer W; Birkmayer JD
    Gerontology; 1987; 33(3-4):168-71. PubMed ID: 3653699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.